These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 15364103

  • 1. The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans.
    Blasi E, Colombari B, Orsi CF, Pinti M, Troiano L, Cossarizza A, Esposito R, Peppoloni S, Mussini C, Neglia R.
    FEMS Immunol Med Microbiol; 2004 Oct 01; 42(2):187-95. PubMed ID: 15364103
    [Abstract] [Full Text] [Related]

  • 2. Influence of indinavir on virulence and growth of Cryptococcus neoformans.
    Monari C, Pericolini E, Bistoni G, Cenci E, Bistoni F, Vecchiarelli A.
    J Infect Dis; 2005 Jan 15; 191(2):307-11. PubMed ID: 15609242
    [Abstract] [Full Text] [Related]

  • 3. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA.
    Parassitologia; 2004 Jun 15; 46(1-2):95-9. PubMed ID: 15305695
    [Abstract] [Full Text] [Related]

  • 4. Indinavir influences biological function of dendritic cells and stimulates antifungal immunity.
    Pericolini E, Cenci E, Gabrielli E, Perito S, Mosci P, Bistoni F, Vecchiarelli A.
    J Leukoc Biol; 2008 May 15; 83(5):1286-94. PubMed ID: 18252869
    [Abstract] [Full Text] [Related]

  • 5. In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors.
    Cassone A, De Bernardis F, Torosantucci A, Tacconelli E, Tumbarello M, Cauda R.
    J Infect Dis; 1999 Aug 15; 180(2):448-53. PubMed ID: 10395861
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antileishmanial activity of HIV protease inhibitors.
    Savoia D, Allice T, Tovo PA.
    Int J Antimicrob Agents; 2005 Jul 15; 26(1):92-4. PubMed ID: 15955671
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Indinavir-treated Cryptococcus neoformans promotes an efficient antifungal immune response in immunosuppressed hosts.
    Pericolini E, Cenci E, Monari C, Perito S, Mosci P, Bistoni G, Vecchiarelli A.
    Med Mycol; 2006 Mar 15; 44(2):119-26. PubMed ID: 16519014
    [Abstract] [Full Text] [Related]

  • 13. Susceptibility of clinical isolates of Cryptococcus neoformans to amphotericin B using time-kill methodology.
    Pappalardo MC, Szeszs MW, Martins MA, Baceti LB, Bonfietti LX, Purisco SU, Baez AA, Melhem MS.
    Diagn Microbiol Infect Dis; 2009 Jun 15; 64(2):146-51. PubMed ID: 19345042
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Conditional lethality of the diprotic weak bases chloroquine and quinacrine against Cryptococcus neoformans.
    Harrison TS, Griffin GE, Levitz SM.
    J Infect Dis; 2000 Jul 15; 182(1):283-9. PubMed ID: 10882608
    [Abstract] [Full Text] [Related]

  • 16. Antifungal drug susceptibility of Cryptococcus neoformans from clinical sources in Nairobi, Kenya.
    Bii CC, Makimura K, Abe S, Taguchi H, Mugasia OM, Revathi G, Wamae NC, Kamiya S.
    Mycoses; 2007 Jan 15; 50(1):25-30. PubMed ID: 17302744
    [Abstract] [Full Text] [Related]

  • 17. Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis.
    Mylonakis E, Moreno R, El Khoury JB, Idnurm A, Heitman J, Calderwood SB, Ausubel FM, Diener A.
    Infect Immun; 2005 Jul 15; 73(7):3842-50. PubMed ID: 15972469
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of beta-1,3-glucan synthase and cell growth of Cryptococcus species by recombinant single-chain anti-idiotypic antibodies.
    Selvakumar D, Miyamoto M, Furuichi Y, Komiyama T.
    J Antibiot (Tokyo); 2006 Feb 15; 59(2):73-9. PubMed ID: 16629406
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.